Drugs / Beta-Alanine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04862533 | Feb 2020 → Aug 2022 | prostate cancer | University Hospital Olomouc | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Beta-Alanine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04862533 ↗ |
| Modality | Small molecule | — CHEMBL297569 ↗ |